Most early-stage breast cancer patients with intermediate Oncotype DX scores do not benefit from chemotherapy; but for young women, a more nuanced examination is required.
YSC RISE Advocates weigh in on the research they’re excited about.
As a researcher whose main role is to engage patients and other stakeholders as we design and conduct a breast cancer clinical trial, RadComp, it is surprising to me that the involvement of patients and other stakeholders has not always been part of the picture.
Urging lawmakers to ensure coverage for all.
Advocating for healthcare equality and fertility options.
Using a grill as a starting point for advocacy.
A veteran journalist and survivor shares her thoughts on advocacy.
RISE Advocate and YSC board member shares her experiences with research advocacy.
Join our campaign and let the world know why you’re an advocate.
Take action for breast cancer awareness month.